Motley Fool  Jun 25  Comment 
These three stocks are transforming the world. In the process, they can also make a massive impact on your retirement portfolio.
Motley Fool  May 9  Comment 
A cut in 2017 outlook for home dialysis products has investors disappointed.
Motley Fool  May 9  Comment 
First-quarter results for the dialysis services company were solid, but the key home market isn't doing as well as hoped.
Motley Fool  May 3  Comment 
Investors are jittery after the kidney-dialysis expert hit an all-time high.
Motley Fool  Feb 28  Comment 
The dialysis company suffered a fourth-quarter loss but sees black ink ahead in the coming year.

You may also be interested in articles related to NxStage Medical (NXTM):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki